Related Experiment Video

Updated: Jun 3, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure

Susan B Gurley1, Anne D M Riquier-Brison2, Jurgen Schnermann3

  • 1Division of Nephrology, Department of Medicine, Duke University and Durham, VA Medical Centers, Durham, NC 27710, USA.

Cell Metabolism
|April 5, 2011
PubMed

Insights

Blocking the renin-angiotensin system (RAS) in kidney proximal tubules lowers blood pressure. This targets epithelial cells, reducing fluid reabsorption and protecting against hypertension.

Area of Science:

  • Nephrology
  • Cardiovascular Physiology
  • Endocrinology

Background:

  • Hypertension impacts over 1.5 billion people globally, with unclear causes in most cases.
  • The renin-angiotensin system (RAS) is a known target for blood pressure (BP) reduction, yet its specific cellular targets remain elusive.
  • Identifying key RAS targets is crucial for developing effective hypertension therapies.

Purpose of the Study:

  • To investigate the role of RAS signaling in the proximal tubule epithelium in regulating blood pressure.
  • To determine if targeting proximal tubule RAS is sufficient to lower BP independently of vascular effects.

Main Methods:

  • Selective abrogation of angiotensin II type 1 (AT(1)) receptor signaling specifically in the proximal tubule epithelium.
  • Assessment of blood pressure changes and renal function.
  • Analysis of fluid reabsorption and sodium transporter expression.

Main Results:

  • Abrogating AT(1) receptor signaling in proximal tubules significantly lowered blood pressure.
  • This intervention reduced proximal tubule fluid reabsorption and altered sodium transporter expression.
  • These changes modified pressure-natriuresis mechanisms, offering protection against hypertension.

Conclusions:

  • RAS actions within the proximal tubule epithelium are critical and nonredundant for BP control.
  • Targeting proximal tubule epithelial cells offers a promising therapeutic strategy for hypertension.
  • This approach modifies renal handling of sodium and fluid, impacting overall blood pressure regulation.

More Related Videos

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli12:19

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Published on: June 27, 2015

Culturing Primary Rat Inner Medullary Collecting Duct Cells06:11

Culturing Primary Rat Inner Medullary Collecting Duct Cells

Published on: June 21, 2013

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...